Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SG 301

Next Previous
Drug Profile

SG 301

Alternative Names: SG-301; SG-301 SC

Latest Information Update: 10 Mar 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hangzhou Sumgen Biotech
  • Class Antineoplastics; Immunotherapies; Monoclonal antibodies
  • Mechanism of Action Antibody-dependent cell cytotoxicity; CD38 antigen inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Multiple myeloma
  • Phase I Haematological malignancies; Systemic lupus erythematosus

Most Recent Events

  • 05 Mar 2026 Hangzhou Sumgen Biotech plans a phase II trial for Systemic lupus erythematosus (Treatment experienced) in China (SC, injection) in March 2026 (NCT07447986)
  • 06 Oct 2025 SG 301 is still in phase-I clinical trials in Systemic lupus erythematosus in China (SC) (Hangzhou Sumgen Biotech pipeline, September 2025)
  • 30 Jul 2025 Sumgen Biotech plans a phase II trial for Nephrotic syndrome (In children, In adolescents) in China (SC) in July 2025 (NCT07087314)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top